Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 7, 2014; 20(45): 17092-17099
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17092
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17092
Figure 5 Expression of Yes-associated protein in SGC-7901 cells after treatment with dobutamine for 72 h.
A: Yes-associated protein (YAP); B: Phosphorylated YAP; C: GAPHD (control). Immunocytochemistry analysis of YAP; D: The expression of YAP was mainly in the nucleus in the absence of dobutamine; E: The expression of phosphorylated YAP was mainly in the cytosol after treatment with dobutamine. GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
- Citation: Zheng HX, Wu LN, Xiao H, Du Q, Liang JF. Inhibitory effects of dobutamine on human gastric adenocarcinoma. World J Gastroenterol 2014; 20(45): 17092-17099
- URL: https://www.wjgnet.com/1007-9327/full/v20/i45/17092.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i45.17092